ArticleCommunications biology2025
Proline-rich 15 depletion enhances Nrf2 cascade to promote osteoblast survival from oxidative injury.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bone Marrow Immunometabolic Remodeling in Osteoporosis: From Systemic Risk Factors to Precision Intervention.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reducing oxidative stress via enhancing Nrf2 cascade activation can efficiently protect osteoblasts. Here siRNA-based screening of nuclear proteins identified PRR15 (proline-rich 15) as a potential regulator of the Nrf2-ARE pathway in osteoblasts. In primary murine osteoblasts, silencing PRR15 using targeted shRNA or CRISPR/Cas9-mediated knockout (KO) enhanced hydrogen peroxide (H₂O₂)-induced activation of the Nrf2 cascade, reducing oxidative stress and cell death. PRR15 silencing or KO also counteracted H₂O₂-induced suppression of proliferation and downregulation of differentiation markers (Runx2 and Col1a1) in murine osteoblasts. Similarly, PRR15 silencing in primary human osteoblasts amplified Nrf2-ARE activation and mitigated H₂O₂-induced oxidative stress. In contrast, PRR15 overexpression inhibited Nrf2 activation, leading to increased apoptosis under oxidative stress in murine osteoblasts. Importantly, Nrf2 silencing by targeted shRNA reversed the protective effects of PRR15 silencing/KO against H₂O₂-induced cytotoxicity in murine osteoblasts. PRR15 interacts with BACH1 (BTB and CNC Homology 1) to negatively regulate Nrf2 signaling, as PRR15 overexpression or silencing had no effect on Nrf2-ARE pathway activation in BACH1-silenced murine osteoblasts. In vivo, osteoblast-specific PRR15 knockdown via adeno-associated virus (AAV) injection reduced oxidative stress and ameliorated trabecular bone loss in ovariectomized mice. Thus PRR15 silencing enhances Nrf2 cascade to promote the survival of osteoblasts exposed to oxidative stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.